What is the price target for VACC stock?
11 analysts have analysed VACC and the average price target is 9.5 USD. This implies a price increase of 89.97% is expected in the next year compared to the current price of 5.
VACCITECH PLC (VACC) Forecast, Price Target & Analyst Ratings
NASDAQ:VACC • US91864C1071
Current stock price
5 USD
+0.51 (+11.36%)
At close:
4.9 USD
-0.1 (-2%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for VACCITECH PLC (VACC).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- N/A
- Period
- Q4 / 2023
- EPS Estimate
- -$0.55
- Revenue Estimate
- 255K
Price Target Details & History
Consensus Price Target and Range
Mean target
$9.50
Upside
+ 89.97%
From current price of $5.00 to mean target of $9.50, Based on 11 analyst forecasts
Low
$3.28
Median
$9.69
High
$15.75
Price Target Revisions
1 Month
0.00%
3 Months
-24.49%
Price Target Summary
11 Wall Street analysts provided a forecast for the next 12 months for VACC. The average price target is 9.5 USD. This implies a price increase of 89.97% is expected in the next year compared to the current price of 5.
The average price target has been revised downward by 24.49% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
81.82%
VACC was analyzed by 11 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about VACC.
In the previous month the buy percentage consensus was at a similar level.
VACC was analyzed by 11 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2023-09-25 | Alliance Global Partners | Initiate | Buy |
| 2023-09-25 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2023-08-18 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-06-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-16 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-03-29 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-27 | HC Wainwright & Co. | Maintains | Buy |
| 2023-03-21 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-08-15 | Morgan Stanley | Maintains | Overweight |
| 2022-08-11 | HC Wainwright & Co. | Maintains | Buy |
| 2022-05-17 | Morgan Stanley | Maintains | Overweight |
| 2022-05-13 | HC Wainwright & Co. | Maintains | Buy |
| 2021-12-15 | HC Wainwright & Co. | Maintains | Buy |
| 2021-05-25 | William Blair | Initiate | Outperform |
| 2021-05-25 | Morgan Stanley | Initiate | Overweight |
| 2021-05-25 | Jefferies | Initiate | Buy |
| 2021-05-24 | HC Wainwright & Co. | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- N/A
- Period
- Q4 / 2023
- EPS Estimate
- -$0.55
- Revenue Estimate
- 255K
- Revenue Q2Q
- -96.05%
- EPS Q2Q
- 3.46%
- Number of Analysts
- 6
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
400.00%
EPS (1 Month)
0.00%
EPS (3 Months)
7.13%
Next Earnings Summary
The next earnings revenue estimate has been revised upward by 400% in the past 3 months. Upward revisions are a positive sign and indicate that analysts are more optimistic about the next earnings compared to 3 months ago.
Full Analyst Estimates 2023 - 2026
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 4.82M -29.64% | 268K -94.44% | 44.703M 16,580.22% | 1.798M -95.98% | 969K -46.11% | 610.98K -36.95% | 1.02M 66.94% | |
| EBITDA YoY % growth | -19.84M 21.61% | -44.619M -124.89% | 282K 100.63% | -93.203M -33,150.53% | -108.66M -16.58% | -132.9M -22.31% | N/A | |
| EBIT YoY % growth | -20.05M 21.86% | -45.221M -125.54% | -4.041M 91.06% | -91.246M -2,158.01% | -96.73M -6.01% | -103.615M -7.12% | -104.295M -0.66% | |
| Operating Margin | -415.98% | -16,873.51% | -9.04% | -5,074.87% | -9,982.46% | -16,958.82% | -10,225.00% | |
| EPS YoY % growth | N/A | -2.10 | 0.13 106.33% | -2.17 -1,733.53% | -1.91 12.21% | -1.89 0.89% | -1.79 5.58% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.55 3.46% | -0.59 -23.25% | -0.59 4.58% | -0.60 -62.65% | -0.60 -9.94% | -0.64 -8.62% | -0.64 -8.62% | -0.65 -8.47% | -0.65 -8.47% | -0.62 3.17% | -0.61 4.76% |
| Revenue Q2Q % growth | 255K -96.05% | 510K 8.97% | -100.00% | -100.00% | -100.00% | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -24.48M 5.98% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
-153.10%
EPS Next 5 Year
-98.17%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
-75.62%
Revenue Next 5 Year
-60.57%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
-191.12%
EBIT Next 5 Year
N/A
VACCITECH PLC / VACC Forecast FAQ
What are the consensus estimates for VACC stock next earnings?
The consensus EPS estimate for the next earnings of VACCITECH PLC (VACC) is -0.55 USD and the consensus revenue estimate is 255.00K USD.
Can you provide the expected long term growth rate for VACCITECH PLC stock?
The expected long term growth rate for VACCITECH PLC (VACC) is -75.62%.